Thursday , October 19 2017
Home / Letter From The Editor / Letter from the Editor: GLP-1 Agonist Options

Letter from the Editor: GLP-1 Agonist Options

By now every one of us has heard that the once weekly version of exenatide, Bydureon, has been delayed by a request for a new study by the FDA. However, many of our colleagues seemed to have forgotten that the twice daily version of exenatide, Byetta, and the once daily version of liraglutide, Victoza (another GLP-1 agonist), are still available. There was a groundswell of excitement that diabetes care would be revolutionized by the once a week version but shouldn’t we be just as excited about the GLP-1 agonists currently available?

After almost 5 years of working with the GLP-1 agonists there are tons of data and information on the value of using these medications, and experience has shown that getting patients to start on these medications can be relatively simple. Why can’t we share the same excitement for these products with our patients that we were going to have for the weekly version?

Thanks to all of you who sent me a note telling me how hard it was to do the breathing exercises that our intern described in our book review of Jumpstart Your Metabolism by Pam Grout. If you have not yet tried them you may want to check it out here.

This week we take a look back at one of the most popular articles that Sheri Colberg, Ph.D., FACSM, has written for us. Check out Five Things Every Person with Diabetes Should Know About Exercise.

Many of you have helped patients avert diabetes disasters and we can all learn from them. If you have a “disaster averted” then send it to us and if we use it you will receive a Visa Gift Card worth $50.00. Click here to let us know the details. (You can use your name or remain anonymous if you prefer.)

Announcements:

TCOYD Conference and Health Fair in San Diego, California, October 30
The TCOYD team will be in San Diego for a conference and health fair event, Saturday, October 30, at the San Diego Convention Center. Special Guests will include Ben Vereen, Doug Cairns, Charlie Kimball and Kim Lyons. For more 2010 upcoming conference details, please go to TCOYD.org.

dLife.com: October 17, 7PM ET on CNBC
Topics: A dLife special presentation of the award-winning “Story of Insulin.” The amazing saga of the discovery of this life-saving drug and how it has made a difference in the lives of millions.¬†Special Guest: Professor Michael Bliss. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.

Please answer this week’s poll (in the right-hand column): Do you ask your patients to report their physical activity?

*****************************
We can make a difference!
*****************************

Check out this week’s “Test Your Diabetes Knowledge” question!

Dave Joffe, Editor-in-chief